Skip to main content
  • 2306 Accesses

Summary

Hopefully, the reader will be able to see the interconnections between nonlinear mixed effects models and linear mixed effects modeling, nonlinear modeling, and linear modeling. The algorithms behind nonlinear mixed effects models are certainly more complex than any of the other model types examined, but the basic ideas behind developing PopPK models are the same as those that were developed using the other classes of models. This chapter has just provided some of the theory behind PopPK models. The next chapter will deal with practical issues in PopPK modeling and the chapter after that will present case studies in PopPK modeling.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Recommended Reading

  • Bruno, R., Vivier, N., Vergnoid, J.C., De Phillips, S.L., Montay, G., and Sheiner, L.B. A population pharmacokinetic model for docetaxel (Taxotere1): Model building and validation. Journal of Pharmacokinetics and Pharmacodynamics 1996; 24: 153–172.

    CAS  Google Scholar 

  • Davidian, M., Giltinan, D.M. Nonlinear models for repeated measurement data. Chapman & Hall, London, 1995.

    Google Scholar 

  • Ette, E.I., and Ludden, T.M. Population pharmacokinetic modeling: The importance of informative graphics. Pharmaceutical Research 1995; 12: 1845–1855.

    Article  CAS  PubMed  Google Scholar 

  • Karlsson, M.O., Jonsson, E.N., Wiltse, C.G., and Wade, J.R. Assumption testing in population pharmacokinetic models: Illustrated with an analysis of moxonidine data from congestive heart failure. Journal of Pharmacokinetics and Pharmacodynamics 1998; 26: 207–246.

    CAS  Google Scholar 

  • Wahlby, U., Jonsson, E.N., and Karlsson, M.O. Assessment of actual significance levels for covariate effects in NONMEM. Journal of Pharmacokinetics and Pharmacodynamics 2001; 28: 321–352. With comments and discussion given in 29; 403–412.

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

(2006). Nonlinear Mixed Effects Models: Theory. In: Pharmacokinetic-Pharmacodynamic Modeling and Simulation. Springer, Boston, MA. https://doi.org/10.1007/0-387-27199-6_7

Download citation

Publish with us

Policies and ethics